Drug Trial Radar · NCT05407064
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
198
Actual
Start
Aug 24, 2022
Primary completion
Oct 6, 2023
Study completion Nov 27, 2023
Sponsor
- Lead sponsor
- Definium Therapeutics US, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 7, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, multi-center, randomized, double-blind, parallel-group, dose-finding study to assess the effect of 4 doses of MM120 (25, 50, 100 or 200 μg freebase-equivalent) for the treatment of anxiety symptoms in subjects diagnosed with generalized anxiety disorder (GAD).
Conditions
- Anxiety Generalized
Interventions
MM120Drug
A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A).
PlaceboOther
A substance that is designed to have no therapeutic value.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose ResponseTime frame: 4 weeks
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners
Little Rock, Arkansas
Irvine Center for Clinical Research
Irvine, California
Kadima Neuropsychiatry Institute
La Jolla, California
Pacific Neuroscience Institute
Santa Monica, California
Mountain View Clinical Research
Denver, Colorado
Wholeness Center
Fort Collins, Colorado
Segal Trials
Lauderhill, Florida
CNS Healthcare - Orlando
Orlando, Florida
iResearch Atlanta
Decatur, Georgia
Great Lakes Clinical Trials
Chicago, Illinois
Uptown Research
Chicago, Illinois
Sunstone Therapies
Rockville, Maryland
SISU
Springfield, Massachusetts
Adams Clinical
Watertown, Massachusetts
Hassman Research Institute
Berlin, New Jersey
GMI - Princeton Medical Institute
Princeton, New Jersey
Lutheran Hospital - Cleveland Clinic
Cleveland, Ohio
BioBehavioral Research of Austin
Austin, Texas
University of Texas Health Houston
Houston, Texas
Cedar Clinical Research
Draper, Utah
Cedar Clinical Research - Murray
Murray, Utah
Woodstock Research Center
Woodstock, Vermont
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.